Hepatocyte steatosis in HCV patients promotes fibrosis by enhancing TGF-β liver expression

Hepatology Research

Volumn 38, Issue 2, 2008, Pages 141-146

  Gabriel, Andrzej ^a   Ziólkowski, Adam ^a   Radlowski, Pawel ^a   Tomaszek, Krzysztof ^a   Dziambor, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Advanced fibrosis; Chronic hepatitis C; Steatosis; TGF expression

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELLULAR DISTRIBUTION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FATTY LIVER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RATING SCALE; SCORING SYSTEM;

EID: 38049123127     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00258.x     Document Type: Article

References (23)

1. Lefkowitch JH, Schiff ER, Davis RL et al. Pathological diagnosis of chronic hepatitis C, a multicenter comparative study with chronic hepatitis C. The Hepatitis Interventional Therapy Group. Gastroenterol 1993; 104: 595-603.
2. Scheuer PJ, Ashrafzadeh P, Sherlock S. The pathology of hepatitis C. Hepatol 1992; 15: 567-71.
3. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatol 2001; 33: 1358-64.
4. Giannini E, Ceppa P, Botta F et al. Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients. Liver 1999; 9: 432-7.
5. Hwang SJ, Luo JC, Chu CW et al. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation. J Gastroenterol Hepatol 2001; 16: 190-5.
6. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: Relative contribution of obesity, diabetes mellitus and alcohol. Hepatol 2002; 36: 729-36.
7. Hourigan LF, MacDonald GA, Purdie D et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatol 1999; 29: 1215-19.
8. Rubbia-Brandt L, Leandro G, Spahr L et al. Liver steatosis in chronic hepatitis C: A morphological sign suggesting infection with HCV genotype 3. Histopathol 2001; 39: 119-24.
9. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol 1999; 34: 85-91.
10. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: A possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001; 34: 428-34.
11. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29: 198-206.
12. Alba LM, Lindor K. Review article: Non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2003; 17: 977-86.
13. Clouston AD, Jonsson JR, Purdie DM et al. Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation. J Hepatol 2001; 34: 314-20.
14. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatol 2002; 36 (Suppl): 47-56.
15. Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming growth factor - Beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1998; 13: 680-4.
16. Gabriel A, Ziólkowski A. New terminology of chronic hepatitis including scoring scale. Med Sci Mon 1997; 3: 113-18.
17. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer S. Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-5.
18. Giannini E, Ceppa P, Botta F et al. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Am J Gastroenterol 2000; 95: 3211-17.
19. Sanyal AJ, Contos MJ, Sterling RK et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with feature of the metabolic syndrome. Am J Gastroenterol 2003; 98: 2064-71.
20. Zafrani ES. Non-alcoholic fatty liver disease: An emerging pathological spectrum. Virch Arch 2004; 444: 3-12.
21. Bachem M, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992; 89: 19-27.
22. Luxon B. Anatomy and physiology of the liver and biliary tree. In: Bacon RB, Di Bisceglie AM, eds. Liver Disease, Diagnosis and Management. New York: Churchill Livingstone, 2000; 10.
23. Wong VS, Wright DGD, Palmer CR, Alexander GJM. Fibrosis and other histological features in chronic hepatitis C virus infection: A statistical model. J Clin Pathol 1996; 49: 465-9.